retatrutide do is a new weight-loss injection, which is currently in its final stages of safety and efficacy trials. UK approval is likely in 2027, pending full MHRA review. Developed by Eli Lilly What to Know About Retatrutide

Glucagon and GLP-1 regulate glucose homeostasis

Researchers report that GLP-1 drugs prescribed for weight loss may improve cognition and lower dementia and cardiovascular disease risk

How long should it be applied each time

Its so tough

It also slows down how quickly your stomach empties, so that feeling of fullness lasts longer

Interestingly, a study that did implement this titration approach found during the maintenance phase, rats treated with semaglutide showed a unexpected marked increase in the intake of lower concentrations of sucrose compared to vehicle treated controls, despite continuing to consume chow at only 90% the level of vehicle-treated animals (Cawthon et al., 2023)